Skip to content

Whitepapers

 

Filter

The role of chimerism monitoring following HSCT

The role of chimerism monitoring following HSCT

Today HSCT is still the only curative treatment for patients with malignant or non-malignant hematological diseases.

Overcoming limitations in the detection of mixed chimerism

Overcoming limitations in the detection of mixed chimerism

This paper highlights the importance of chimerism as a diagnostic tool for clinicians treating transplanted patients.

A new NGS-based method for Chimerism monitoring

A new NGS-based method for Chimerism monitoring

New, highly sensitive and precise methods for mixed chimerism analytics are transforming post-transplant monitoring, enabling earlier detection and treatment to save the lives of transplanted.